InvestorsHub Logo
icon url

peewee

06/07/10 9:20 AM

#68978 RE: califax #68934

ax...Antisoma is a real nice runner here ! :-)
icon url

peewee

06/07/10 6:35 PM

#69001 RE: califax #68934

Among biotech stocks, British minnow Antisoma (ASM.L), whose stock plunged 70 percent in March when a lung cancer drug it was developing with Novartis failed in a Phase III trial, saw a partial revival in its fortunes on hopes for other drugs in earlier-stage development.

Shares in Antisoma, which presented updates on both AS1413 and AS1411 at ASCO, rose 21 percent. (Reporting by Ben Hirschler in London and Lewis Krauskopf in New York; Editing by Karen Foster and Maureen Bavdek)

http://www.reuters.com/article/idCNN0714001720100607?rpc=44